Agency Information Collection Activities; Proposed Collection; Public Comment Request, 51333-51334 [2014-19793]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices
These reporting and third party
disclosure requirements aid the
Commission monitoring advance marine
vessel tracking and navigation
information transmitted from Class B
AIS devices to ensure that they are
accurate and reliable, while promoting
marine safety.
Federal Communications Commission.
Gloria J. Miles,
Federal Register Liaison, Office of the
Secretary, Office of the Managing Director.
[FR Doc. 2014–20432 Filed 8–27–14; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
pmangrum on DSK3VPTVN1PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 24,
2014.
A. Federal Reserve Bank of
Philadelphia (William Lang, Senior Vice
President) 100 North 6th Street,
Philadelphia, Pennsylvania 19105–
1521:
1. Beneficial Bancorp, Inc.,
Philadelphia, Pennsylvania; to become a
bank holding company by acquiring 100
percent of the voting shares of
VerDate Mar<15>2010
14:14 Aug 27, 2014
Jkt 232001
Beneficial Mutual Savings Bank,
Philadelphia, Pennsylvania, and all of
its nonbanking subsidiaries, upon its
conversion to a bank.
In connection with this proposal,
Beneficial Savings Bank MHC, and
Beneficial Mutual Bancorp, Inc., both in
Philadelphia, Pennsylvania, will
convert stock form and merge with
Beneficial Bancorp, Inc., Philadelphia,
Pennsylvania.
B. Federal Reserve Bank of New York
(Ivan Hurwitz, Vice President) 33
Liberty Street, New York, New York
10045–0001:
1. CIT Group Inc., Livingston, New
Jersey, and its subsidiary, Carbon
Merger Sub LLC, New York, New York;
to acquire 100 percent of the voting
shares of, and thereby merge with, IMB
HoldCo LLC, and thereby indirectly
acquire voting shares of OneWest Bank,
N.A., both in Pasadena, California. In
addition, Carbon Merger Sub LLC also
has applied to a become bank holding
company.
Board of Governors of the Federal Reserve
System, August 25, 2014.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2014–20497 Filed 8–27–14; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: HHS–OS0990–new–
60D]
Agency Information Collection
Activities; Proposed Collection; Public
Comment Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, announces plans
to submit a new Information Collection
Request (ICR), described below; to the
Office of Management and Budget
(OMB). Prior to submitting that ICR to
OMB, OS seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on the ICR must be
received on or before October 27, 2014.
ADDRESSES: Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–6162.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
51333
When
submitting comments or requesting
information, please include the
document identifier HHS–OS–0990–
New–60D for reference.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Information Collection Request Title:
Tissue and Organ Donor Epidemiology
Study (TODES), OMB # 0990-New
request, Office of the Assistant Secretary
for Health.
Abstract: This Study is a request for
a new data collection OMB Number:
0990-New TODES is being conducted in
order to better understand the impact of
donor screening and selection
procedures, and to determine the extent
of donor-donation level data that are
collected for organ and tissue (including
ocular) donors. The data that are
obtained from Organ Procurement
Organizations (OPOs) and Eye Banks
will provide a better characterization of
the deceased donor pool; information
regarding data management and storage
practices; and a measure of the degree
of standardization of data collected by
various organizations across the U.S.
TODES may provide better estimates of
the risk of HIV, HBV and HCV
infections associated with organ and
tissue transplantation and the potential
for disease transmission; illustrate
differences in laboratory screening
methods and the impact of protocol
variations; and serve as a pilot for future
studies. This retrospective study will
provide a framework for future,
prospective studies of organ and tissue
donors that could inform policy
decisions regarding donor qualification
procedures and, potentially, increase
the donor pool.
A workshop in June 2005
(‘‘Preventing Organ and Tissue
Allograft-Transmitted Infection:
Priorities for Public Health
Intervention’’) identified gaps in organ
and tissue safety in the United States.1
Participants developed a series of
allograft safety initiatives, assessed
progress, and identified priorities for
future interventions. Despite progress,
improved recognition and prevention of
donor-derived transmission events is
needed. It was concluded that this
requires systems integration across the
organ and tissue transplantation
communities including organ
procurement organizations, eye and
tissue banks, and transplant infectious
disease experts. Commitment of
resources and improved coordination of
efforts are required to develop essential
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28AUN1.SGM
28AUN1
51334
Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices
tools to enhance safety for transplant
recipients.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Number of
responses
per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total annual
burden hours
OPOs ...............................................................................................................
Eye Banks ........................................................................................................
17
7
1
1
85/60
55/60
24.1
6.4
Total ..........................................................................................................
........................
........................
........................
30.5
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2014–19793 Filed 8–27–14; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; HIV Study in Blood
Donors From Five Chinese Regions
(NHLBI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register in Volume 79, June
12, 2014 on page 33764 and allowed 60days for public comment. One public
comment was received that was a
personal opinion regarding conducting
research about the Chinese blood
donation system. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health (NIH) may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
14:14 Aug 27, 2014
Jkt 232001
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
For Further Information: To obtain a
copy of the data collection plans and
instruments or request more information
on the proposed project contact: Simone
Glynn, MD, Project Officer/ICD Contact,
Two Rockledge Center, Suite 9142, 6701
Rockledge Drive, Bethesda, MD 20892,
or call 301–435–0065, or Email your
request, including your address to:
glynnsa@nhlbi.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Proposed Collection: HIV Study in
Blood Donors from Five Chinese
Regions, 0925–0596 reinstatement with
change, National Heart, Lung and Blood
Institute (NHLBI).
Need and Use of Information
Collection: This Study is a reinstatement
with change of OMB Number: 0925–
0596 expiration date, January 31, 2012.
To better understand the diversifying
and changing Human
Immunodeficiency Virus (HIV)
epidemic, and contemporary HIV risk
factors, especially those associated with
recent HIV infections, this HIV risk
factor study in China is proposed as part
of the Recipient Epidemiology and
Donor Evaluation Study-III (REDS–III).
The major objectives of the study will be
to evaluate the proportion of blood
donors in China who test positive for
HIV and have acquired their infection
recently or more remotely; the risk of
releasing a blood product that contains
HIV (HIV residual risk); and the risk
factors associated with HIV infection in
China. The study will also assess the
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
frequency of distinct HIV–1 viral
lineages and drug resistant mutations
among HIV-positive blood donors. In
2011, there were 780,000 people
infected with HIV in China and it is
estimated that over 300,000 HIV
infected people in China are not aware
of their infection status. The large
migrating population and the
complexity of HIV transmission routes
in China make it difficult to implement
a comprehensive and effective national
HIV control strategy. Risk factors for
infections can change over time; thus,
identifying factors that contribute to the
recent spread of HIV in a broad crosssection of an otherwise unselected
general population, such as blood
donors, is highly important for
obtaining a complete picture of the
epidemiology of HIV infection in China.
Because the pace of globalization means
infections can cross borders easily, the
study objectives have direct relevance
for HIV control in the US and globally.
Recent years have seen an increase in
blood donations from repeat donors in
most Chinese regions. This increase
permits longer-term follow-up and
testing of repeat donors which allow for
calculation of new HIV infection rates
and residual risks. The HIV data, for
both recently and remotely acquired
infections, from the proposed study will
complement existing data on HIV risks
obtained from general and high risk
populations to provide comprehensive
HIV surveillance data for China. This
study will also monitor genetic
characteristics of recently acquired
infections through genotyping and drug
resistance testing, thus serving a US and
global public health imperative to
monitor the genotypes of HIV that have
recently been transmitted. For HIV, the
additional monitoring of drug resistance
patterns in newly acquired infection is
critical to determine if currently
available antiretroviral medicines are
capable of combating infection.
Genotyping and host response
information are scientifically important
not only to China, but to the US and
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 79, Number 167 (Thursday, August 28, 2014)]
[Notices]
[Pages 51333-51334]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19793]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: HHS-OS0990-new-60D]
Agency Information Collection Activities; Proposed Collection;
Public Comment Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the Office of the Secretary (OS), Department of
Health and Human Services, announces plans to submit a new Information
Collection Request (ICR), described below; to the Office of Management
and Budget (OMB). Prior to submitting that ICR to OMB, OS seeks
comments from the public regarding the burden estimate, below, or any
other aspect of the ICR.
DATES: Comments on the ICR must be received on or before October 27,
2014.
ADDRESSES: Submit your comments to
Information.CollectionClearance@hhs.gov or by calling (202) 690-6162.
FOR FURTHER INFORMATION CONTACT: Information Collection Clearance
staff, Information.CollectionClearance@hhs.gov or (202) 690-6162.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the document identifier HHS-OS-0990-New-60D
for reference.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Information Collection Request Title: Tissue and Organ Donor
Epidemiology Study (TODES), OMB 0990-New request, Office of
the Assistant Secretary for Health.
Abstract: This Study is a request for a new data collection OMB
Number: 0990-New TODES is being conducted in order to better understand
the impact of donor screening and selection procedures, and to
determine the extent of donor-donation level data that are collected
for organ and tissue (including ocular) donors. The data that are
obtained from Organ Procurement Organizations (OPOs) and Eye Banks will
provide a better characterization of the deceased donor pool;
information regarding data management and storage practices; and a
measure of the degree of standardization of data collected by various
organizations across the U.S. TODES may provide better estimates of the
risk of HIV, HBV and HCV infections associated with organ and tissue
transplantation and the potential for disease transmission; illustrate
differences in laboratory screening methods and the impact of protocol
variations; and serve as a pilot for future studies. This retrospective
study will provide a framework for future, prospective studies of organ
and tissue donors that could inform policy decisions regarding donor
qualification procedures and, potentially, increase the donor pool.
A workshop in June 2005 (``Preventing Organ and Tissue Allograft-
Transmitted Infection: Priorities for Public Health Intervention'')
identified gaps in organ and tissue safety in the United States.1
Participants developed a series of allograft safety initiatives,
assessed progress, and identified priorities for future interventions.
Despite progress, improved recognition and prevention of donor-derived
transmission events is needed. It was concluded that this requires
systems integration across the organ and tissue transplantation
communities including organ procurement organizations, eye and tissue
banks, and transplant infectious disease experts. Commitment of
resources and improved coordination of efforts are required to develop
essential
[[Page 51334]]
tools to enhance safety for transplant recipients.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total annual
Type of respondents respondents responses per response (in burden hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
OPOs............................................ 17 1 85/60 24.1
Eye Banks....................................... 7 1 55/60 6.4
---------------------------------------------------------------
Total....................................... .............. .............. .............. 30.5
----------------------------------------------------------------------------------------------------------------
OS specifically requests comments on (1) the necessity and utility
of the proposed information collection for the proper performance of
the agency's functions, (2) the accuracy of the estimated burden, (3)
ways to enhance the quality, utility, and clarity of the information to
be collected, and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2014-19793 Filed 8-27-14; 8:45 am]
BILLING CODE 4150-28-P
